Official FDA signals
Uses openFDA animal adverse-event reports as supporting signals. Reports alone do not establish causation or incidence.
Select medicines and an animal species to review interaction risks, sources and evidence limits. Supports clinical review and does not replace licensed veterinary judgment.
Every result states whether it is a direct rule, controlled extrapolation, FDA signal or an evidence gap.
Sources include official information, literature and restricted textbooks. Check the scope and review status of each conclusion separately.
Uses openFDA animal adverse-event reports as supporting signals. Reports alone do not establish causation or incidence.
PubMed provides literature citations and abstracts; PMC archives full text. Evidence strength and reuse permissions must be checked article by article.
Publication review and verified-veterinarian feedback are shown separately. Administrator approval is not independent clinical validation.
Check permissions source by source. Restricted textbook originals are not republished on public pages.
ZooDDI separates direct evidence, extrapolation, supporting signals and unmatched results. This editorial guide explains the result types; it is not a treatment protocol.
Scroll horizontally to read all table columns.
| Result type | What it tells you | What to verify |
|---|---|---|
| Direct evidence | A source explicitly addresses the selected species and drug combination. | Check the source wording, route, formulation and review status. Read the methodology |
| Cross-species extrapolation | A source species or mechanism provides a lead for further review. | This does not establish the effect or safety in the target species. Read the extrapolation limits |
| FDA signal | Adverse-event reports provide context for investigation. | Reports do not establish causation or provide an incidence estimate. [1] |
| No matching rule | The current published data returned no rule for that species and combination. | No match does not establish safety; review other sources. See coverage limits |
These official documents explain source scope and permissions. They do not imply FDA or NLM endorsement of ZooDDI. Clinical conclusions need the specific references in each evidence article.
Read English evidence articles with specific clinical references
Search avian species, reptiles, small mammals, amphibians and ornamental fish. Coverage depends on published rules; a missing match does not establish safety.
The same risk results and evidence. Choose by how often you check.
US$0 / month
50checks / month
US$9 / month
Or US$79 / year, billed annually
1,000checks / month
Sign in to subscribe
Sign in to confirm checkout and manage your subscription.One completed prescription check counts once, including no-match results; failed checks do not count. Paid Pro resets each subscription month from activation; annual Pro still includes 1,000 checks per month. Free resets on the first at 00:00 UTC. Unused checks do not roll over.
Payment does not change evidence grades. Veterinary certification and rule-rating eligibility are verified separately.
Launch allowances shown. Sign in to confirm your current allowance.
Evidence type, source status and review status are shown separately. Qualifiers such as may and other source uncertainty are preserved.
Read our public sources, methodology and service limitations before use. Clinical conclusions require the specific source and patient context.
Understanding cross-species extrapolation · Understanding FDA animal safety signals
Read our public methodology and coverage limitations.Put prescriptions, species and risk into one direct clinical HUD. High risks appear first; numbered evidence supports drill-down without presenting inference as certainty.
Confirm route and formulationMedicine BCheck the species scopeAn actual result needs its source, species scope and review status. This illustration makes no clinical claim about a drug combination.
Interface illustration, not a diagnosis, prescription or measured accuracy.
Choose or type avian, reptile, small mammal, amphibian and ornamental fish species. More specificity makes review more targeted.
When a result comes from a homologous species or pharmacokinetic mechanism, ZooDDI shows the source species, confidence and cautions instead of calling it a verified rule.
Only a direct rule's review state can be shown as verified. FDA adverse events are supporting signals and cannot alone establish causality.
From prescription input to consensus review, ZooDDI keeps the context of species, citations, source status and uncertainty.
Start with Phase 1 exotic groups or enter the exact species.
Select medicines and the patient species to check every added combination.
Confirm direct evidence, extrapolation, FDA signal or evidence gap before making a clinical decision.
From direct species evidence to source species, inference confidence, FDA supporting signals, source status and review state, every layer keeps an auditable boundary.
Only sources explicitly marked “Original file archived” provide a downloadable original for review.
No. It provides evidence and risk signals; the prescribing decision remains with a licensed veterinarian.
No. Extrapolation shows source species, confidence and cautions. It is a review prompt, not a substitute for species-specific evidence.
No. FDA adverse-event reports are supporting signals and cannot alone establish causality, incidence or comparative product risk.